Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

935 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
STK19 facilitates the clearance of lesion-stalled RNAPII during transcription-coupled DNA repair.
van den Heuvel D, Rodríguez-Martínez M, van der Meer PJ, Moreno NN, Park J, Kim HS, van Schie JJM, Wondergem AP, D'Souza A, Yakoub G, Herlihy AE, Kashyap K, Boissière T, Walker J, Mitter R, Apelt K, de Lint K, Kirdök I, Ljungman M, Wolthuis RMF, Cramer P, Schärer OD, Kokic G, Svejstrup JQ, Luijsterburg MS. van den Heuvel D, et al. bioRxiv [Preprint]. 2024 Jul 22:2024.07.22.604575. doi: 10.1101/2024.07.22.604575. bioRxiv. 2024. Update in: Cell. 2024 Dec 12;187(25):7107-7125.e25. doi: 10.1016/j.cell.2024.10.018 PMID: 39091731 Free PMC article. Updated. Preprint.
STK19 facilitates the clearance of lesion-stalled RNAPII during transcription-coupled DNA repair.
van den Heuvel D, Rodríguez-Martínez M, van der Meer PJ, Nieto Moreno N, Park J, Kim HS, van Schie JJM, Wondergem AP, D'Souza A, Yakoub G, Herlihy AE, Kashyap K, Boissière T, Walker J, Mitter R, Apelt K, de Lint K, Kirdök I, Ljungman M, Wolthuis RMF, Cramer P, Schärer OD, Kokic G, Svejstrup JQ, Luijsterburg MS. van den Heuvel D, et al. Among authors: d souza a. Cell. 2024 Dec 12;187(25):7107-7125.e25. doi: 10.1016/j.cell.2024.10.018. Epub 2024 Nov 14. Cell. 2024. PMID: 39547229 Free article.
Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma (LITESPARK-003): an open-label, single-arm, phase 2 study.
Choueiri TK, Merchan JR, Figlin R, McDermott DF, Arrowsmith E, Michaelson MD, Tykodi SS, Heath EI, Spigel DR, D'Souza A, Kassalow L, Perini RF, Vickery D, Bauer TM. Choueiri TK, et al. Among authors: d souza a. Lancet Oncol. 2025 Jan;26(1):64-73. doi: 10.1016/S1470-2045(24)00649-1. Lancet Oncol. 2025. PMID: 39756444 Clinical Trial.
935 results